United States next generation sequencing
market is expected to grow at a significant rate during the forecast period. Strong economic growth of United States is enabling the
concerned authorities to allocate huge funds for the research and development
activities which is expected to fuel the demand for next generation sequencing
in laboratories. Rise in disposable income of the consumers is increasing the
healthcare expenditure of people. Next generation sequencing helps to devise
effective treatments and formulate drugs with better outcomes.
High-end
investments by the major players for technological advancement and use of
better equipment and tools for next generation sequencing is expected to
influence the market growth. Next generation sequencing is highly sensitive to
variants whose frequency is low. It has the ability to sequence a large number
of genes simultaneously with fast turn around time. Higher amount of data is
generated within a sample of DNA than the other present technologies. Next
generation sequencing is widely used for infectious disease surveillance for
producing high quality results. Increasing prevalence of terminal diseases
requires the effective treatment strategies which can be obtained through next
generation sequencing technology.
United
States next generation sequencing market is segmented into product, technology, application, end
user, regional distribution, and company. Based on end user, market is further divided into academic
& clinical research centers, pharmaceutical & biotechnology companies,
hospitals & clinics, and others. The academic & clinical research
centers segment is expected to account for major market share for the forecast
period, 2023-2027. Applications of next generation sequencing for research
projects is driving the demand in academic centers. Moreover, the scholarships
offered to study next generation sequencing for Ph.D. is expected to foster the
market growth.
The major players operating in the United
States next generation sequencing market are Illumina,
Inc., Thermo Fischer Scientific, Inc., Roche Diagnostics Corporation, Agilent Technologies,
Inc., PerkinElmer Inc., Pacific Biosciences of California Inc, 10x Genomics
Inc., Amgen Inc., Bio-Rad Laboratories, Inc., QIAGEN Inc., among others. Major
companies are developing advanced technologies and launching new services to
stay competitive in the market. Other competitive strategies include mergers
& acquisitions and new service developments.
Objective of the Study:
- To analyze the historical growth of the market size of United
States next generation sequencing market from 2017 to 2020.
- To estimate and forecast the market size of United States next
generation sequencing market from 2021 to 2027 and growth rate until 2027.
- To classify and forecast United States next generation sequencing market
based on product, technology, application, end user, regional distribution,
and company.
- To identify dominant region or segment in the United States next
generation sequencing.
- To identify drivers and challenges for United States next
generation sequencing market.
- To examine competitive developments such as expansions, new product
launches, mergers & acquisitions, etc., in United States next
generation sequencing market.
- To identify and analyze the profile of leading players operating in
United States next generation sequencing market.
- To identify key sustainable strategies adopted by market players in
United States next generation sequencing market.
Click here to download the sample
TechSci Research performed both primary as well as exhaustive
secondary research for this study. Initially, TechSci Research sourced a list
of service providers across the globe. Subsequently, TechSci Research conducted
primary research surveys with the identified companies. While interviewing, the
respondents were also enquired about their competitors. Through this technique,
TechSci Research could include the service providers who could not be
identified due to the limitations of secondary research. TechSci Research
analyzed the service providers, distribution channels and presence of all major
players across the globe.
TechSci
Research calculated the market size of United States next generation sequencing market using a
bottom-up approach, wherein data for various end-user segments was recorded and
forecast for the future years. TechSci Research sourced these values from the
industry experts and company representatives and externally validated through
analyzing historical data of these product types and applications for getting
an appropriate, overall market size. Various secondary sources such as company
websites, news articles, press releases, company annual reports, investor
presentations and financial reports were also studied by TechSci Research.
Key Target Audience:
- Next generation sequencing provider companies
- Market research and consulting firms
- Government bodies such as regulating
authorities and policy makers
- Organizations, forums, and alliances related
to next generation sequencing market.
The study is useful in providing answers to several critical
questions that are important for the industry stakeholders such as service
providers, suppliers and partners, end users, etc., besides allowing them in
strategizing investments and capitalizing on market opportunities.
|
Attribute
|
Details
|
|
Base
Year
|
2021
|
|
Historical
Years
|
2017 –
2020
|
|
Estimated
Year
|
2022E
|
|
Forecast
Period
|
2023F –
2027F
|
|
Quantitative
Units
|
Revenue in
USD Million and CAGR for 2017-2021 and 2022E-2027F
|
|
Report
Coverage
|
Revenue
forecast, company share, competitive landscape, growth factors, and trends
|
|
Segments
Covered | - Product
- Technology
- Application
- End User
|
|
Region
Scope
|
South-Region,
West-Region, Mid-West Region & Northeast-Region
|
|
Key
Companies Profiled
|
Illumina,
Inc., Thermo Fischer Scientific, Inc., Roche Diagnostics Corporation, Agilent
Technologies, Inc., PerkinElmer Inc., Pacific Biosciences of California Inc,
10x Genomics Inc., Amgen Inc., Bio-Rad Laboratories, Inc., QIAGEN Inc.
|
|
Customization
Scope
|
10% free
report customization with purchase. Addition or alteration to regional &
segment scope.
|
|
Pricing
and Purchase Options
|
Avail customized
purchase options to meet your exact research needs. Explore purchase options
|
|
Delivery
Format
|
PDF and Excel through Email (We can also
provide the editable version of the report in PPT/Word format on special
request)
|
Report Scope:
In this report, United States next
generation sequencing market has been segmented into following categories, in
addition to the industry trends which have also been detailed below:
·
United States Next Generation Sequencing
Market, By Product:
- Consumables
- Platforms
- Services
- United States Next Generation Sequencing Market, By Technology:
- Sequencing
by Synthesis
- Ion
Semiconductor Sequencing
- Sequencing
by Ligation
- Single
Molecule Real Time Sequencing
- Others
- United States Next Generation Sequencing Market, By Application:
- Biomarkers
& Cancer
- Diagnostics
- Reproductive
Health
- Personalized
Medicine
- Agriculture
& Animal Research
- Others
- United States Next Generation Sequencing Market, By End
User:
- Academic
& Clinical Research Centers
- Pharmaceutical
& Biotechnology Companies
- Hospitals
& Clinics
- Others
- United States Next Generation Sequencing Market, By Region:
- South
- West
- Mid-West
- North East
Competitive
Landscape
Company Profiles: Detailed analysis of the major
companies present in United States next generation sequencing market.
Available Customizations:
With the given market data, TechSci Research offers
customizations according to a company’s specific needs. The following
customization options are available for the report:
Company Information
- Detailed analysis and profiling of
additional market players (up to five).
United States next
generation sequencing market is an upcoming report to be released soon. If you
wish an early delivery of this report or want to confirm the date of release,
please contact us at [email protected]